Kewaunee Scientific CORP /DE/ 8-K filings

Kewaunee Scientific Corporation announced plans to release its financial results for the fourth quarter and full fiscal year ended April 30, 2026, after market close on June 23, 2026.

Kewaunee Scientific Corporation announced it will release its third quarter fiscal year 2026 financial results on March 11, 2026.

Kewaunee Scientific Corporation announced its second quarter fiscal year 2026 results, reporting a significant increase in sales driven by the Nu Aire acquisition, despite a decline in net earnings.

Kewaunee Scientific Corporation successfully refinanced its debt and fully repaid $23.0 million in Seller Notes related to its Nu Aire acquisition ahead of schedule, reducing interest expense.

Kewaunee Scientific Corporation announced it will release its second quarter fiscal year 2026 financial results on December 10, 2025.

Kewaunee Scientific Corporation announced the appointment of J. Jette Campbell to its Board of Directors and an amendment to its bylaws regarding board size.

Kewaunee Scientific Corporation announced significant sales and earnings growth for its first quarter of fiscal year 2026, driven by the Nu Aire acquisition and improved productivity.

Kewaunee Scientific Corporation announced the results of its Annual Meeting, including the re-election of two Class III directors and the ratification of its independent auditors.

Kewaunee Scientific Corporation announced it will release its first quarter fiscal year 2026 financial results on September 10, 2025.

Kewaunee Scientific Corporation announced its fiscal year 2025 results, highlighting significant sales growth and the strategic acquisition of NuAire, Inc., despite a decrease in reported net earnings.

Kewaunee Scientific Corporation announced strong financial results for its fiscal year and fourth quarter ended April 30, 2025, highlighted by significant sales growth and improved adjusted profitability, bolstered by the strategic acquisition of Nu Aire, Inc.

Kewaunee Scientific Corporation announced it will release its financial results for the fourth quarter and fiscal year ended April 30, 2025, on Wednesday, June 25, 2025, after the close of trading.

Kewaunee Scientific Corporation has amended its share repurchase program, authorizing the repurchase of up to an additional 100,000 shares of its common stock.

Kewaunee Scientific Corporation announces a 43.6% increase in sales for Q3 2025, but pre-tax earnings decreased due to acquisition and integration costs related to Nu Aire.

Kewaunee Scientific Corporation (NASDAQ: KEQU) will release its third quarter fiscal year 2025 financial results on March 12, 2025, after the close of trading.

Kewaunee Scientific Corporation completes the acquisition of Nu Aire, Inc. for $55 million, expanding its offerings in the medical and research fields.

Kewaunee Scientific Corporation announced its second quarter fiscal year 2025 results, showing a decrease in overall sales and pre-tax earnings, but an increase in net earnings and a record backlog, while also incurring costs related to the acquisition of Nu Aire, Inc.

Kewaunee Scientific Corporation will release its second quarter fiscal year 2025 financial results on December 11, 2024, after the close of trading.

Kewaunee Scientific Corporation has successfully acquired Nu Aire for $55 million, expanding its product portfolio and market reach in the laboratory furniture and technical products sector.

Kewaunee Scientific's first quarter of fiscal year 2025 saw a slight decrease in sales and earnings compared to the prior year, with international sales impacted by project delays in India.

Kewaunee Scientific Corporation held its annual shareholder meeting on August 28, 2024, where a director was re-elected, the company's auditor was ratified, and executive compensation was approved on an advisory basis.

Kewaunee Scientific Corporation will release its first quarter fiscal year 2025 financial results on September 11, 2024, after the close of trading.

Kewaunee Scientific Corporation reported strong fiscal year 2024 results, driven by strategic decisions and a robust order backlog, despite a slight decrease in year-over-year sales.

Kewaunee Scientific Corporation announced a 5% increase in fourth-quarter sales and significant improvements in full-year earnings, driven by strategic go-to-market decisions and non-recurring gains.

Kewaunee Scientific Corporation will release its financial results for the fourth quarter and fiscal year ended April 30, 2024, on June 26, 2024, after market close.

Kewaunee Scientific Corporation will terminate its pension plan effective April 30, 2024, transferring approximately $17.7 million in pension obligations through the purchase of group annuity contracts.

Kewaunee Scientific Corporation has granted its CEO, Thomas D. Hull III, a $250,000 retention bonus to ensure his continued service for the next 36 months.

Kewaunee Scientific Corporation announced a 70.6% increase in pre-tax earnings for the third quarter of fiscal year 2024, despite a 23.1% decrease in sales compared to the same period last year.

Kewaunee Scientific Corporation will release its third quarter fiscal year 2024 financial results on March 6, 2024, after the close of trading.